Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02563834 · ClinicalTrials.gov registry record · NA
A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02563834: Completed NA study, sponsored by Indiana University.
NCT02563834 is a NA study that has completed, run by Indiana University. The registered enrollment target is 18 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02563834, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
Studies of myocardial fuel selection using a novel palmitate-based PET probe
Primary Outcome
PET measure of fatty acid uptake rate
Interventions
- DRUG Saline
- DRUG Insulin
- DRUG thiapalmitate tracer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-06 |
| Phase | NA |
What the finished NCT02563834 record still lists
NCT02563834 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 18 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Saline is the first listed.
NCT02563834 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02563834 about?
NCT02563834 is a clinical study titled "A Novel Positron Emission Tomography (PET) Approach to Measuring Myocardial Metabolism". Studies of myocardial fuel selection using a novel palmitate-based PET probe
What is the current status of trial NCT02563834?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-01. Estimated completion is 2009-06.
What interventions are being tested in trial NCT02563834?
The interventions under investigation include: Saline (DRUG), Insulin (DRUG), thiapalmitate tracer (DRUG).
Who is sponsoring clinical trial NCT02563834?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02563834's enrollment target sits among peer trials
18 1863rd of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia